Back to Top

Advertisement

Policy Positions

1818 Council on Public Policy

FEDERAL QUALITY RATING PROGRAM FOR PHARMACEUTICAL MANUFACTURERS

1819 Council on Public Policy

INTRAVENOUS FLUID MANUFACTURING FACILITIES AS CRITICAL PUBLIC HEALTH INFRASTRUCTURE

1820 Council on Public Policy

MEDICAL DEVICES

1821 Council on Therapeutics

ENSURING EFFECTIVENESS, SAFETY, AND ACCESS TO ORPHAN DRUG PRODUCTS

1822 Council on Therapeutics

RATIONAL USE OF MEDICATIONS

1823 Council on Therapeutics

RESPONSIBLE MEDICATION-RELATED CLINICAL TESTING AND MONITORING (Superseded)

1824 Council on Therapeutics

USE OF BIOMARKERS IN CLINICAL PRACTICE

1825 Council on Education and Workforce Development

CLINICIAN WELL-BEING AND RESILIENCE (Superseded)

1826 Council on Education and Workforce Development

STUDENT PHARMACIST DRUG TESTING

1827 Council on Education and Workforce Development

COLLABORATION ON EXPERIENTIAL EDUCATION

Showing 281-290 of 966

Prev

29
OF 97

Next